Litcius/Paper detail

Incidence and Estimated Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection Among Persons Tested in US Retail Locations, May 1 to August 7, 2021

Ying P. Tabak, Xiaowu Sun, Troyen A. Brennan, Sreekanth K. Chaguturu

2021JAMA Network Open17 citationsDOIOpen Access PDF

Abstract

This case-control study evaluates the estimated vaccine effectiveness against infection changes over time to help inform public health policy and clinical practices.

Topics & Concepts

Incidence (geometry)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakMedicineVirologyEnvironmental healthDemographyInternal medicineOutbreakDiseaseInfectious disease (medical specialty)MathematicsGeometrySociologySARS-CoV-2 and COVID-19 ResearchVaccine Coverage and HesitancyCOVID-19 epidemiological studies
Incidence and Estimated Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection Among Persons Tested in US Retail Locations, May 1 to August 7, 2021 | Litcius